Preclinical News and Research

RSS
Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Vismodegib therapy effective against medulloblastoma

Vismodegib therapy effective against medulloblastoma

Moerae announces initiation of second MMI-0100 Phase 1 clinical trial for pulmonary disorders

Moerae announces initiation of second MMI-0100 Phase 1 clinical trial for pulmonary disorders

Researchers establish safety, dosing of new drug for treating blood cancers

Researchers establish safety, dosing of new drug for treating blood cancers

Regeneron, Sanofi to jointly advance new immuno-oncology treatment options for cancer patients

Regeneron, Sanofi to jointly advance new immuno-oncology treatment options for cancer patients

SutroVax completes $22 million Series A financing

SutroVax completes $22 million Series A financing

Important new target identified for ovarian cancer therapy

Important new target identified for ovarian cancer therapy

Gene responsible for cancer growth plays unexpected role in prostate cancer

Gene responsible for cancer growth plays unexpected role in prostate cancer

Dairy products could make probiotics more effective

Dairy products could make probiotics more effective

KalVista raises $33 million in Series B financing to support development of plasma kallikrein inhibitors

KalVista raises $33 million in Series B financing to support development of plasma kallikrein inhibitors

MGB Biopharma begins MGB-BP-3 Phase I clinical trial for treatment of Clostridium difficile infections

MGB Biopharma begins MGB-BP-3 Phase I clinical trial for treatment of Clostridium difficile infections

Mayo Clinic researchers test Spheroid Reservoir Bioartificial Liver to treat patients with acute liver failure

Mayo Clinic researchers test Spheroid Reservoir Bioartificial Liver to treat patients with acute liver failure

C2N-8E12 (ABBV-8E12) gets orphan drug designation from FDA for PSP treatment

C2N-8E12 (ABBV-8E12) gets orphan drug designation from FDA for PSP treatment

Adverse life events in childhood can increase woman's risk of preterm birth

Adverse life events in childhood can increase woman's risk of preterm birth

Novogen's Anisina granted FDA Orphan Drug Designation for neuroblastoma

Novogen's Anisina granted FDA Orphan Drug Designation for neuroblastoma

New drug DSM265 shows potential to cure, prevent malaria

New drug DSM265 shows potential to cure, prevent malaria

UK investment lacking for pneumonia research

UK investment lacking for pneumonia research

Oxford University performs second phase of experimental Ebola vaccine trial

Oxford University performs second phase of experimental Ebola vaccine trial

IU researcher plays role in recent FDA approval of Neupogen drug to treat people exposed to radiation

IU researcher plays role in recent FDA approval of Neupogen drug to treat people exposed to radiation

MR Solutions unveils preclinical, cryogen-free MRI systems at ISMRM 2015 and SNMMI 2015

MR Solutions unveils preclinical, cryogen-free MRI systems at ISMRM 2015 and SNMMI 2015

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.